Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Amortization - Intangibles (2009 - 2026)

Charles River Laboratories International (CRL) posted Amortization - Intangibles of $14.6 million for Q2 2026, down 4.93% on a QoQ basis from $15.3 million in Q1 2026, and down 77.69% year-over-year from $65.4 million in Q2 2025.

Analysis

Charles River Laboratories International (CRL) Amortization - Intangibles (2009 - 2026) Analysis & Trends

Charles River Laboratories International has reported Amortization - Intangibles for 18 years, with the latest figure at $14.6 million in Q2 2026.

  • On a quarterly basis, Amortization - Intangibles fell 77.69% year-over-year to $14.6 million in Q2 2026; TTM through Jun 2026 was $78.3 million, a 61.66% decrease from a year earlier, with the FY2025 full-year figure at $179.1 million, up 29.31% from the prior year.
  • Amortization - Intangibles was $14.6 million for Q2 2026 at Charles River Laboratories International, down from $15.3 million in the prior quarter.
  • The five-year high for Amortization - Intangibles was $65.4 million in Q2 2025, with the low at $14.6 million in Q2 2026.
  • Average Amortization - Intangibles over 5 years is $35.1 million, with a median of $34.3 million recorded in 2023.
  • The sharpest annual moves came in 2025 and 2026: Amortization - Intangibles surged 102.43% in 2025, then slumped 77.69% in 2026.
  • Over 5 years, Amortization - Intangibles stood at $35.5 million in 2022, then fell by 4.05% to $34.0 million in 2023, then grew by 21.25% to $41.3 million in 2024, then tumbled by 49.09% to $21.0 million in 2025, then tumbled by 30.53% to $14.6 million in 2026.
  • The last three Amortization - Intangibles figures came in at $14.6 million (Q2 2026), $15.3 million (Q1 2026), and $21.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 14.59 Mn
Mar 28, 2026 15.35 Mn
Dec 27, 2025 21.00 Mn
Sep 27, 2025 27.40 Mn
Jun 28, 2025 65.38 Mn
Mar 29, 2025 65.30 Mn
Dec 28, 2024 41.25 Mn
Sep 28, 2024 32.40 Mn
Jun 29, 2024 32.30 Mn
Mar 30, 2024 32.60 Mn
Dec 30, 2023 34.02 Mn
Sep 30, 2023 34.23 Mn
Jul 1, 2023 34.30 Mn
Apr 1, 2023 34.92 Mn
Dec 31, 2022 35.46 Mn
Sep 24, 2022 35.53 Mn
Jun 25, 2022 37.60 Mn
Mar 26, 2022 38.01 Mn
Dec 25, 2021 30.24 Mn
Sep 25, 2021 32.85 Mn